Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: A single-institution experience

Oncology

Volumn 73, Issue 5-6, 2008, Pages 311-315

  Manzione, Luigi ^a   Romano, Rosangela ^a   Germano, Domenico ^a,b  

^a Medical Oncology   (Italy)

^b NONE   (Italy)

Author keywords

Biliary tract cancers; Chemotherapy; Gemcitabine; Oxaliplatin

Indexed keywords

GEMCITABINE; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BILIARY TRACT CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; INFECTION; LIVER DYSFUNCTION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT REFUSAL; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45549093154     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134239     Document Type: Article

References (33)

1. De Groen PC, Gores GJ, La Russo NF, et al: Biliary tract cancers. N Engl J Med 1999;341:1368-1378.
2. Falkson G, Macintyre JM, Moertel CG: Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984;54:965-969.
3. Glimelius B, Hoffman K, Sjoden PO: Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600.
4. Takada T, Kato H, Matsushiro T, et al: Combination of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas. Oncology 1994;51:396-400.
5. Kajanti M, Pyrhönen S: Epirubicin-sequential methotrexate-5- fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 1994;17:223-226.
6. Gallardo JO, Rubio B, Fodor M, et al: A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol 2001;12:1403-1406.
7. Dragovich T, Ramanathan R, Remick S, et al: Phase II trial of a weekly 150-minute gemcitabine infusion in patients with biliary tree carcinomas (abstract 1159). Proc Am Soc Clin Oncol 2000;19:264a.
8. Verderame F, Mandina P, Abruzzo F, et al: Biliary tract cancer: our experience with gemcitabine treatment. Anticancer Drugs 2000;11:707-708.
9. Kubicka S, Rudolph KL, Tietze MK, et al: A phase II study of gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 2001;48:783-789.
10. Penz M, Kornek GV, Raderer M, et al: Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 2001;12:183-186.
11. Reyes-Vidal J, Gallardo J, Yanez E, et al: Gemcitabine and cisplatin in the treatment of patients with unresectable or metastatic gall-bladder cancer: results of the phase II Gocchi study 2000-13 (abstract 1095). Proc Am Soc Clin Oncol 2003;22:273.
12. Dorval DC, Sekhon JS, Gupta SK, et al: A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 2004;90:1516-1520.
13. Nehls O, Oettle H, Hartmann J-T, et al: Multicenter phase II trial of oxaliplatin plus capecitabine (XELOX) in advanced biliary system adenocarcinomas (study CCC/GBC-01) (abstract 1126). Proc Am Soc Clin Oncol 2003;22:280.
14. Mavroudis D, Kouroussis C, Kakolyris S, et al: Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report. Semin Oncol 2000;27(suppl 1):25-30.
15. Shibata S, Chow W, Frankel P, et al: A phase I trial of oxaliplatin in combination with gemcitabine: a California Consortium Trial. ASCO Proc 381, 2001, vol 20, part 1.
16. Faivre S, Raymond E, Lokiec F: Final results of the phase I-II and pharmacokinetic study GEM/OX combining gemcitabine (Gem) with oxaliplatin (Ox) in patients (pts) with advanced non-small cell lung (NSCLC) and ovarian carcinoma (OC). ASCO Proc 2105, 2001, vol 20, part 2.
17. Franciosi V, Barbieri R, Vasini G, et al: A feasible combination of gemcitabine and oxaliplatin in patients with advanced non small cell lung cancer. Preliminary results of a phase II study. ASCO Proc 2804, 2001, vol. 20, part 2.
18. Louvet C, AndréT, Lledo G, et al: Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J Clin Oncol 2002;20:1512-1518.
19. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
20. Gebbia V, Giuliani F, Maiello E, et al: Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 2001;19:4089-4091.
21. Taieb J, Mitry E, Boige V, et al: Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol 2002;13:1192-1196.
22. Hsu C, Shen Y-C, Yang C-H, et al: Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. Br J Cancer 2004;90:1715-1719.
23. Kuhn R, Hribaschek A, Eichelmann K, et al: Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. Invest New Drugs 2002;20:351-356.
24. Rao S, Cunningham D, Hawkins RE, et al: Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer 2005;92:1650-1654.
25. Kornek GV, Schuell B, Laengle F, et al: Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomized phase II trial. Ann Oncol 2004;15:770-774.
26. Cho JY, Paik YH, Chang YS, et al: Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer 2005;104:2753-2758.
27. Knox JJ, Hedley D, Oza A, et al: Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Ann Oncol 2004;15:770-774.
28. Knox JJ, Hedley D, Oza A, et al: Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 2005;23:2332-2338.
29. Kim ST, Park JO, Lee J, et al: A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 2006;106:1339-1346.
30. Verderame F, Russo A, Di Leo R, et al: Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann Oncol 2006;17(suppl 7):vii68-vii72.
31. Mavroudis D, Pappas P, Kouroussis C, et al: A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumours. Ann Oncol 2003;14:304-312.
32. AndréT, Tournigand C, Rosmorduc O, et al: Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: A GERCOR study. Ann Oncol 2004;15:1339-1343.
33. Germano D, Rosati G, Manzione L: Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience. J Chemother 2007;19:577-581.